In this study, researchers from different universities in Thailand evaluated the effects of acute and chronic rosmarinic acid treatment on blood pressure and skeletal muscle glucose transport in angiotensin II-induced hypertensive rats. Their findings were published in the journal
BMC Complementary and Alternative Medicine.
- Herbs that belong to the Lamiaceae (mint) family, such as rosemary, sage, basil and mint, contain rosmarinic acid (RA).
- According to previous studies, RA exhibits inhibitory effects against angiotensin-converting enzyme and functions as a vasodilator.
- Angiotensin II (ANG II) is a peptide hormone linked to hypertension and oxidative stress.
- Hypertension, meanwhile, is strongly related to insulin resistance.
- To determine the effects of RA treatment, the researchers used eight-week-old rats as test subjects.
- They divided the rats into SHAM and ANG II-infused (250 ng/kg/min) groups and gave some of the mice in the second group 10, 20 or 40 mg/kg RA.
- They then evaluated the mice's body weight, liver and heart weights, oral glucose tolerance, skeletal muscle glucose transport activity and signaling proteins.
- The researchers reported that acute and chronic RA treatment decreased systolic, diastolic and mean arterial blood pressure in the rats.
- Only acute RA (40 mg/kg) treatment reduced fasting plasma glucose levels and induced skeletal muscle glucose transport.
- These effects appeared to be due to increased ERK activity in the skeletal muscles.
- Chronic RA treatment with 10, 20, and 40 mg/kg prevented ANG II-induced hyperglycemia.
Based on these findings, the researchers concluded that
rosmarinic acid treatment is an effective alternative strategy for improving skeletal muscle glucose transport and protecting against ANG II-induced hypertension and hyperglycemia.
Read the full study
at this link.
Journal Reference:
Prasannarong M, Saengsirisuwan V, Surapongchai J, Buniam J, Chukijrungroat N, Rattanavichit Y. ROSMARINIC ACID IMPROVES HYPERTENSION AND SKELETAL MUSCLE GLUCOSE TRANSPORT IN ANGIOTENSIN II-TREATED RATS. BMC Complementary and Alternative Medicine. 08 July 2019;19(1). DOI:
10.1186/s12906-019-2579-4